Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

NCT04783857 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04783857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04783857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Lead sponsor
University of Minnesota
Phase
Phase 4
Overall status
Recruiting
Start date
April 14, 2022
Completion date
June 2, 2027
Enrollment
171 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking, smoking cessation, smoking reduction